3932-0040 Screening compound: 5-[3-(6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid

3932-0040 Screening compound: 5-[3-(6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid
3932-0040 Screening compound: 5-[3-(6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound 3932-0040
5-[3-(6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3932-0040

Molecular Formula

C31H29ClN4O4 (C31 H29 ClN4 O4)

Compound Name

5-[3-(6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid

IUPAC name

5-[3-(6-chloro-2-oxo-4-phenyl-12-dihydroquinolin-3-yl)-5-[4-(dimethylamino)phenyl]-45-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid

SMILES

CN(C)c1ccc(C(C2)N(C(CCCC(O)=O)=O)N=C2C2=C(c3ccccc3)c(cc(cc3)Cl)c3NC2=O)cc1

InChI

InChI=1S/C31H29ClN4O4/c1-35(2)22-14-11-19(12-15-22)26-18-25(34-36(26)27(37)9-6-10-28(38)39)30-29(20-7-4-3-5-8-20)23-17-21(32)13-16-24(23)33-31(30)40/h3-5,7-8,11-17,26H,6,9-10,18H2,1-2H3,(H,33,40)(H,38,39)/t26-/m1/s1

InChI Key

UFOQJQPRTHUDAK-AREMUKBSSA-N

MDL Number (MFCD)

MFCD11223935

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

557.05

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.960

Distribution Coefficient, logD

2.363

Water Solubility, LogSw

-4.84

Polar Surface Area

82.653

Acid Dissociation Constant (pKa)

4.80

Base Dissociation Constant (pKb)

5.34

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.60

3932-0040 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Integrin Receptors Targeted library (1715 compounds)

MCL1 Targeted Library (12200 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Others

References: we are preparing a list of scientific research reports with 3932-0040 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3932-0040?
Check Price and Availability of 3932-0040, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3932-0040 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3932-0040
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3932-0040
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3932-0040 available by request